
Eastman Chemical Company (NYSE:EMN – Free Report) – Zacks Research decreased their FY2026 earnings estimates for shares of Eastman Chemical in a report issued on Friday, November 13th. Zacks Research analyst Team now expects that the basic materials company will post earnings per share of $6.05 for the year, down from their previous estimate of $6.39. Zacks Research has a “Strong Sell” rating on the stock. The consensus estimate for Eastman Chemical’s current full-year earnings is $6.10 per share. Zacks Research also issued estimates for Eastman Chemical’s Q4 2026 earnings at $1.15 EPS, Q1 2027 earnings at $1.38 EPS, Q2 2027 earnings at $1.81 EPS, Q3 2027 earnings at $1.78 EPS, Q4 2027 earnings at $1.54 EPS, FY2027 earnings at $6.52 EPS, Q1 2028 earnings at $1.51 EPS, Q2 2028 earnings at $1.80 EPS, Q3 2028 earnings at $1.79 EPS and FY2028 earnings at $6.60 EPS.
Eastman Chemical (NYSE:EMN – Get Free Report) last issued its quarterly earnings results on Thursday, October 29th. The basic materials company reported $1.84 earnings per share for the quarter, missing analysts’ consensus estimates of $1.92 by ($0.08). The company had revenue of $2.38 billion during the quarter, compared to analyst estimates of $2.41 billion. Eastman Chemical had a return on equity of 10.59% and a net margin of 7.15%. The company’s revenue was up 8.3% on a year-over-year basis. During the same period in the prior year, the company posted $1.14 earnings per share.
A number of other equities analysts have also issued reports on the company. The Goldman Sachs Group reaffirmed a “neutral” rating and set a $72.00 price target on shares of Eastman Chemical in a research note on Monday, November 2nd. Wall Street Zen downgraded Eastman Chemical from a “buy” rating to a “hold” rating in a research note on Saturday, September 12th. UBS Group dropped their price objective on Eastman Chemical from $92.00 to $77.00 and set a “buy” rating on the stock in a research note on Monday, October 5th. Mizuho cut their price objective on Eastman Chemical from $85.00 to $80.00 and set an “outperform” rating for the company in a report on Thursday, October 1st. Finally, Barclays raised their target price on Eastman Chemical from $72.00 to $74.00 and gave the company an “equal weight” rating in a research note on Monday, November 2nd. Six analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $74.79.
Check Out Our Latest Stock Analysis on EMN
Eastman Chemical Price Performance
Shares of NYSE:EMN opened at $63.40 on Monday. Eastman Chemical has a 12 month low of $56.11 and a 12 month high of $83.47. The stock has a market cap of $7.25 billion, a price-to-earnings ratio of 11.26, a PEG ratio of 0.91 and a beta of 1.07. The stock’s 50 day moving average price is $65.39 and its 200 day moving average price is $70.75. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.57 and a quick ratio of 0.79.
Institutional Trading of Eastman Chemical
Several institutional investors and hedge funds have recently added to or reduced their stakes in EMN. Worldquant Millennium Advisors LLC bought a new position in shares of Eastman Chemical in the third quarter valued at $2,593,000. Entropy Technologies LP bought a new stake in shares of Eastman Chemical during the 3rd quarter worth $3,968,000. Jump Financial LLC boosted its stake in shares of Eastman Chemical by 261.2% during the 3rd quarter. Jump Financial LLC now owns 43,506 shares of the basic materials company’s stock worth $2,821,000 after acquiring an additional 31,461 shares in the last quarter. EP Wealth Advisors LLC bought a new stake in shares of Eastman Chemical during the 3rd quarter worth $551,000. Finally, Empowered Funds LLC grew its holdings in shares of Eastman Chemical by 13.8% in the 3rd quarter. Empowered Funds LLC now owns 73,382 shares of the basic materials company’s stock worth $4,758,000 after acquiring an additional 8,924 shares during the last quarter. 83.65% of the stock is owned by institutional investors and hedge funds.
Eastman Chemical News Roundup
These are some of the EMN news items that stood out recently:
- Positive Sentiment: Zacks raised select quarterly estimates, including Q2 2027 EPS to $1.81 from $1.73 and Q2 2028 EPS to $1.80 from $1.78. These increases are modest compared with the broader cuts. Article: Zacks Research Predicts Lower Earnings for Eastman Chemical
- Negative Sentiment: Zacks cut its full-year EPS projections to $6.05 for 2026 (from $6.39), $6.52 for 2027 (from $6.76), and $6.60 for 2028 (from $6.93). It also reduced estimates for Q4 2026 and Q1 2027, pointing to softer expected earnings across multiple periods. Article: Zacks Research Predicts Lower Earnings for Eastman Chemical
Eastman Chemical Company Profile
Eastman Chemical Company is a global specialty materials and chemicals company founded in 1920 in Kingsport, Tennessee. Originally part of Eastman Kodak, it became an independent company in 1994. Eastman develops and manufactures materials and chemical products for customers in a wide range of industries. Its products include specialty plastics and films, performance additives, chemical intermediates, and cellulose acetate fibers. These materials are used in applications such as transportation, building and construction, consumer goods, electronics, packaging, and healthcare.
Recommended Stories
- Five stocks we like better than Eastman Chemical
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Eastman Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eastman Chemical and related companies with MarketBeat.com's FREE daily email newsletter.
